Centro de Investigación de Medicina Aplicada (CIMA)
Centro / Instituto vinculado a la Universidad de Navarra
Jesús J.
Sola
Publicaciones en las que colabora con Jesús J. Sola (16)
2015
-
Immune monitoring of immunosuppression withdrawal of liver transplant recipients
Transplant Immunology, Vol. 33, Núm. 2, pp. 110-116
2014
-
Characterization of the CD40L/Oncostatin M/Oncostatin M receptor axis as an antiviral and immunostimulatory system disrupted in chronic HCV infection
Journal of Hepatology, Vol. 60, Núm. 3, pp. 482-489
2013
-
Trial of complete weaning from immunosuppression for liver transplant recipients: Factors predictive of tolerance
Liver Transplantation, Vol. 19, Núm. 9, pp. 937-944
2012
-
Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: A validation phase II trial
International Journal of Radiation Oncology Biology Physics, Vol. 83, Núm. 2, pp. 587-593
2011
-
MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells
Stem Cells, Vol. 29, Núm. 11, pp. 1661-1671
-
Patterns of response after preoperative intensity-modulated radiation therapy and capecitabine/oxaliplatin in rectal cancer: Is there still a place for ecoendoscopic ultrasound?
International Journal of Radiation Oncology Biology Physics, Vol. 81, Núm. 2, pp. 439-444
-
Patterns of response after preoperative treatment in gastric cancer
International Journal of Radiation Oncology Biology Physics, Vol. 80, Núm. 3, pp. 698-704
2010
-
A new mutation in the hMSH2 gene in a Spanish Lynch syndrome family
Clinical and Translational Oncology, Vol. 12, Núm. 12, pp. 849-851
-
Sequential administration of dose-dense epirubicin/cyclophosphamide followed by docetaxel/capecitabine for patients with HER2-negative and locally advanced or node-positive breast cancer
Cancer Chemotherapy and Pharmacology, Vol. 65, Núm. 3, pp. 457-465
2009
-
microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells
Clinical Cancer Research, Vol. 15, Núm. 7, pp. 2281-2290
2008
-
Phase I-II Trial of Concurrent Capecitabine and Oxaliplatin With Preoperative Intensity-Modulated Radiotherapy in Patients With Locally Advanced Rectal Cancer
International Journal of Radiation Oncology Biology Physics, Vol. 71, Núm. 3, pp. 748-755
2007
-
Induction of immunosuppressive molecules and regulatory T cells counteracts the antitumor effect of interleukin-12-based gene therapy in a transgenic mouse model of liver cancer
Journal of Hepatology, Vol. 47, Núm. 6, pp. 807-815
2005
-
Intratumoral injection of dendritic cells engineered to secrete interleukin-12 by recombinant adenovirus in patients with metastatic gastrointestinal carcinomas
Journal of Clinical Oncology, Vol. 23, Núm. 5, pp. 999-1010
2004
-
Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors
Journal of Clinical Oncology, Vol. 22, Núm. 8, pp. 1389-1397
2003
-
The diffuse endocrine system: From embryogenesis to carcinogenesis
Progress in Histochemistry and Cytochemistry, Vol. 38, Núm. 2, pp. 153-272
1997
-
Cardiomyocyte apoptosis and cardiac angiotensin-converting enzyme in spontaneously hypertensive rats
Hypertension, Vol. 30, Núm. 5, pp. 1029-1034